Liver Support for Acute Hepatic Failure/MOF

Patients with acute hepatic failure (with or without multiple organ failure) can be supported while awaiting liver recovery or as bridge to transplantation. Several support technologies have been and are being explored for liver support, such as albumin dialysis (MARS), sorbent-augmented dialysis, and the bioartificial liver. These therapies are currently not available for commercial use.

LSUHSC provides liver support with coupled plasma filtration/absorption and hemofiltration, which removes plasma from the circulation and treats it before returning it back to the circulation. This therapy is optionally supplemented with therapeutic plasma exchange (TPE) as needed.

Criteria for referral

Patients may be candidates for support with the following conditions. These are guidelines only, so all potential referrals should be discussed with the ECLS physician.

Toxin- or drug-induced liver injury
Post hepatic resection or transplantation
Acute-on-chronic failure due to reversible intercurrent illness

How to contact us

ECLS Coordinator

Sheree Jordan, RN, BSN, MSN
   Office: 318-675-7610
   Pager: 318-683-8907
   Mobile: 318-518-7289
   mjorda@lsuhsc.edu

ECLS Program Director

Steven Conrad, MD PhD
   MICU: 318-675-7215
   Pager: 1-877-772-8543
   sconrad@lsuhsc.edu